on April 10, 2013 |
Permalink
Topics: Cardiovascular, Service Lines, Cardiac Cath, Cardiac Surgery, Clinical Technology
Megan Tooley, Cardiovascular Roundtable
For those of you who missed it, I wanted to share a recent blog post by our colleagues at the Advisory Board’s Technology Insights program, “TAVR Poised for Further Market Expansion,” which provides an overview of the latest research on transcatheter valves presented at the 2013 American College of Cardiology Scientific Sessions in San Francisco.
Continue reading:
TAVR highlights from ACC 2013
on January 14, 2013 |
Permalink
Topics: Cardiovascular, Service Lines, Cardiac Cath, Cardiac Surgery, Regionalization and Networks, Strategy, Service Line Growth, Volume Growth, Technology Assessment, Planning, Program Infrastructure, Business Development
Megan Tooley, Cardiovascular Roundtable
There is no question the emergence of transcatheter valve technologies—specifically transcatheter aortic valve replacement (TAVR)—has elicited unprecedented excitement from the cardiovascular community in recent years. However, despite this enthusiasm, the reality is only a portion of hospitals will meet the strict resource and volume requirements necessary to become TAVR sites in the near future.
This may leave many of you wondering, “So what if we’re not a TAVR program? Is there still a place for us in the valve market?” You’re not alone, and as we explore in our national meeting series, your options for treating valve disease and disorders do not end at TAVR.
Learn how one Roundtable member is ensuring their patients have access to a full range of valve services—even if they’re not the TAVR program.
Continue reading:
So you're not a TAVR program—Now what?
on January 10, 2013 |
Permalink
Topics: Cardiovascular, Service Lines, Cardiac Surgery, Cardiac Cath, Patient Satisfaction, Quality, Performance Improvement
Nicole MacMillan, Cardiovascular Roundtable
With the recent release of the Society for Cardiovascular Angiography and Interventions’ (SCAI) consensus statement on ad hoc PCI, the discussion around informed consent for cardiac procedures has again risen to the forefront of our members’ topics of interest.
One study we discussed previously suggests that patient education surrounding elective PCI decisions is often infrequent and ripe for improvement. This dialogue with patients will become increasingly critical as providers seek to activate patients in their care to secure both loyalty and engagement throughout the treatment process.
Continue reading:
Informed consent for cardiovascular procedures: Resources for your program
